secwatch.observer — SEC 8-K summary
======================================

Issuer:     Endo International plc (—)
CIK:        0001593034
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001193125-24-100879
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 1.03
LLM model:  deepseek-v4-flash:cloud@v2

Endo signs asset sale agreement under confirmed Chapter 11 Plan
---------------------------------------------------------------

- On April 14, 2024, Endo entered into a Purchase and Sale Agreement with Endo Enterprise, Endo USA, and Paladin Pharma to sell substantially all assets.
- The Bankruptcy Court confirmed the Chapter 11 Plan on March 22, 2024; the sale is a key step toward emergence.
- Closing conditions include HSR clearance, Irish regulatory approval, and entry of a final Confirmation Order.
- No purchase price disclosed in the filing; the agreement's full text is attached as Exhibit 2.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593034/000119312524100879/0001193125-24-100879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593034/000119312524100879/d787795d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-100879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer